Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | LPAR6 | P43657 | 2/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.30 |
| ▸ | LPAR4 | Q99677 | 2/20 | 0.30 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12134032 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL6178482 | 0.97 | ALDH1A1 (0.37) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL8017511 | 0.92 | — | — | |
| SCHEMBL11030766 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL13864131 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL5159311 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL5163869 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL2742856 | 0.87 | ALDH1A1 (0.32) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL4609242 | 0.85 | ALDH1A1 (0.41) | ALDH1A1TSHRL3MBTL1DNM1SMN1; SMN2 | |
| SCHEMBL25566315 | 0.84 | ALDH1A1 (0.40) | ALDH1A1TSHRL3MBTL1SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355626-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV HEALTHCARE UK (NO. 5) LIMITED (GB) | 2023-11-09 | — | — | US | disclosed |
| US-11702429-B2 | mTORC modulators and uses thereof | AEOVIAN PHARMACEUTICALS, INC. (US) | 2023-07-18 | — | — | US | disclosed |
| WO-2017075351-A1 | POLYURETHANE BINDER CONTAINING ALCOHOL SOLVENT | ASK CHEMICALS, L.P. (US) | 2017-05-04 | — | — | WO | disclosed |
| US-20160083398-A1 | DIARYLETHENE COMPOUNDS AND USES THEREOF | SWITCH MATERIALS, INC. (CA) | 2016-03-24 | — | — | US | disclosed |
| EP-2598550-B1 | BINDER SYSTEM BASED ON POLYURETHANE FOR PRODUCING CORES AND CASTING MOLDS USING CYCLIC FORMALDEHYDES, MOLDING MATERIAL MIXTURE, AND METHOD | ASK CHEMICALS GMBH (DE) | 2014-12-31 | — | — | EP | disclosed |
| US-20140300031-A1 | BINDER SYSTEM BASED ON POLYURETHANE FOR PRODUCING CORES AND CASTING MOLDS USING CYCLIC FORMALS, MOLDING MATERIAL MIXTURE, AND METHOD | ASK CHEMICALS GMBH (DE) | 2014-10-09 | — | — | US | disclosed |
| EP-2598550-A1 | BINDER SYSTEM BASED ON POLYURETHANE FOR PRODUCING CORES AND CASTING MOLDS USING CYCLIC FORMALDEHYDES, MOLDING MATERIAL MIXTURE, AND METHOD | ASK Chemicals GmbH (DE) | 2013-06-05 | — | — | EP | disclosed |
| US-8383583-B2 | Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors | ENANTA PHARMACEUTICALS, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| WO-2012025084-A1 | BINDER SYSTEM BASED ON POLYURETHANE FOR PRODUCING CORES AND CASTING MOLDS USING CYCLIC FORMALDEHYDES, MOLDING MATERIAL MIXTURE, AND METHOD | ASK CHEMICALS GMBH (DE) | 2012-03-01 | — | — | WO | disclosed |
| US-20090123425-A1 | MACROCYCLIC, PYRIDAZINONE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS | ENANTA PHARMACEUTICALS, INC. | 2009-05-14 | — | — | US | disclosed |
| US-4172068-A | POLYOL, POLYISOCYANATE; ACETAL OR KETAL AS SOLVENT | INTERNATIONAL MINERALS & CHEMICAL CORPORATION (US) | 1979-10-23 | — | — | US | disclosed |
| US-4116916-A | BINDER, PHENOL-FORMALDEHYDE RESIN, POLYISOCYANATE, SOLVENT | INTERNATIONAL MINERALS & CHEMICAL CORP. (US) | 1978-09-26 | — | — | US | disclosed |
| US-4051092-A | CURABLE RESIN, POLYISOCYANATE | INTERNATIONAL MINERALS & CHEMICAL CORPORATION (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702429-B2 | mTORC modulators and uses thereof | MTOR, RICTOR, RPTOR | ALDH1A1 4766/4885TSHR 3270/4885L3MBTL1 1721/4885 |
| US-20090123425-A1 | MACROCYCLIC, PYRIDAZINONE-CONTAINING HEPATITIS C SERINE PROTEASE INHIBITORS | PRSS1, SPINT2, TMPRSS4 | ALDH1A1 958/4885TSHR 4400/4885L3MBTL1 3766/4885 |
| US-20230355626-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | EIF2AK2, POLR2E, POLR2H | ALDH1A1 2912/4885TSHR 4832/4885L3MBTL1 2208/4885 |
| US-20160083398-A1 | DIARYLETHENE COMPOUNDS AND USES THEREOF | KCNH2, KCNH3, SCN2B | ALDH1A1 1014/4885TSHR 797/4885L3MBTL1 3851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.